Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 296 entries
View as:

A Phase 1b Open Label, Dose Escalation Study of PLX3397 in Combination With Vemurafenib in V600-mutated BRAF Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01826448 Org: User:
Start: 11/05/13 End: 09/22/14 Due: 09/22/15

Effects of Colesevelam on How the Body Responds to Insulin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00147745 Org: User:
Start: 06/30/05 End: 01/31/08 Due: 01/31/09

Observational Study to Evaluate the Simplified-STroke REhabilitation Assessment of Movement (S-STREAM) Scale in Subjects Who Have Experienced a Nonhemorrhagic Ischemic Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01496885 Org: User:
Start: 01/18/12 End: 05/22/13 Due: 05/22/14

Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT01496365 Org: User:
Start: 11/28/11 End: 09/07/12 Due: 09/07/13

A Study to Determine the Absolute Oral Bioavailability of Quizartinib Using a Radiolabeled Microtracer in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04796831 Org: User:
Start: 04/26/21 End: 06/11/21 Due: 06/11/22

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05950945 Org: User:
Start: 12/30/23 End: 10/01/27 Due: 10/01/28

Olmesartan Comparison to Losartan in Hypertensive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00949884 Org: User:
Start: 08/31/09 End: 01/31/10 Due: 01/31/11

Safety, Tolerability and Pharmacokinetics of Milademetan Alone and With 5-Azacitidine (AZA) in Acute Myelogenous Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT02319369 Org: User:
Start: 11/25/14 End: 08/21/20 Due: 08/21/21

A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02790684 Org: User:
Start: 05/31/16 End: 06/30/16 Due: 06/30/17

Treatment of Pain Associated With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT02187471 Org: User:
Start: 01/16/15 End: 01/12/17 Due: 01/12/18

An Observational Study Investigating the Change in Blood Cholesterol With Mevalotin® Tablet Administration in Korean Menopausal Women Aged 50 Years or More Who Require Treatment of Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT05120895 Org: User:
Start: 08/10/21 End: 04/30/25 Due: 04/30/26

Efficacy of SUN N4057 in Subjects With Acute Ischemic Stroke and Measurable Penumbra on Magnetic Resonance Imaging (MRI)

Phase: N/A Priority: Normal
NCT ID: NCT00272909 Org: User:
Start: 09/30/04 End: 01/31/07 Due: 01/31/08

Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00185133 Org: User:
Start: 05/31/05 End: 01/31/07 Due: 01/31/08

HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04676477 Org: User:
Start: 06/11/21 End: 04/30/27 Due: 04/30/28

Study to Assess Safety, Tolerability, and Pharmacokinetics of Oral Doses for AC430 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01287858 Org: User:
Start: 11/30/10 End: 06/30/11 Due: 06/30/12

Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Phase: N/A Priority: Normal
NCT ID: NCT04519944 Org: User:
Start: 06/30/20 End: 07/06/23 Due: 07/06/24

Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00872586 Org: User:
Start: 08/31/06 End: 08/31/07 Due: 08/31/08

Safety Study of PLX108-01 in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01004861 Org: User:
Start: 10/01/09 End: 10/25/18 Due: 10/25/19

Effect of Repeated Doses of DS-8500a on Pharmacokinetics of Rosuvastatin in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03699774 Org: User:
Start: 05/12/15 End: 07/06/15 Due: 07/06/16

Exatecan Mesylate in Treating Children With Relapsed or Refractory Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00055939 Org: User:
Start: 01/31/03 End: 04/30/06 Due: 04/30/07

Safety Study of DS-5565 for Treatment of Fibromyalgia Pain in Subjects With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT02496884 Org: User:
Start: 06/26/15 End: 07/06/17 Due: 07/06/18

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)

Phase: N/A Priority: Normal
NCT ID: NCT02371369 Org: User:
Start: 05/11/15 End: 04/30/21 Due: 04/30/22

Chemotherapy in Treating Women With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00004046 Org: User:
Start: 06/30/99 End: 04/30/02 Due: 04/30/03

Edoxaban Management in Diagnostic and Therapeutic Procedures

Phase: N/A Priority: Normal
NCT ID: NCT02950168 Org: User:
Start: 11/30/16 End: 07/26/18 Due: 07/26/19

Ifinatamab Deruxtecan (I-DXd) in Subjects With Pretreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05280470 Org: User:
Start: 03/09/22 End: 11/15/25 Due: 11/15/26